You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 20 No. 3, March 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (60)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Niemann-Pick Disease

Morphologic and Biochemical Studies in the Visceral Form With Late Central Nervous System Involvement (Crocker's Group C)

M. Philippart, MD; L. Martin, MD; J. J. Martin, MD; John H. Menkes, MD

Arch Neurol. 1969;20(3):227-238.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

NIEMANN-PICK disease is characterized by the accumulation of sphingomyelin in the reticuloendothelial system of the liver, spleen, bone marrow, and lymph nodes. Alterations in the brain are variable and range from no involvement to a picture of a diffuse neuronal storage disease. Over the last ten years it has become evident that Niemann-Pick disease does not represent a single clinical and biochemical entity, but that there may at least be four conditions in which there is tissue storage of sphingomyelin.1-3

About 85% of patients fall into group A1 (classic Niemann-Pick disease) characterized by the onset of hepatosplenomegaly during the first year of life, intellectual deterioration, and the frequent presence of retinal cherry-red spots. Death usually occurs prior to 3 years of age. The essential pathological changes in this condition are the massive and generalized deposition of foam cells, and the presence of ballooned ganglion cells in various . . . [Full Text PDF of this Article]


Author Affiliations

Los Angeles; Antwerp, Belgium; Los Angeles

From the Department of Pediatrics and Medicine (Neurology), the University of California at Los Angeles (Drs. Philippart and Menkes) and the Department of Neuropathology, Born-Bunge Foundation, Berchem-Antwerp (Dr. L. Martin). Dr. J. J. Martin is a Research Fellow, Belgian FNRS.


Footnotes

Submitted for publication Sept 30, 1968; accepted Oct 17.

Read before the 20th Meeting of the American Academy of Neurology, April 26, 1968.

Reprint requests to Department of Pediatrics, University of California, Los Angeles 90024 (Dr. Philippart).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.